168 related articles for article (PubMed ID: 36499298)
21. Comparison of prednisolone acetate and loteprednol etabonate for the treatment of benzalkonium chloride-induced dry eye syndrome in rats.
Beyazyıldız E; Acar U; Beyazyıldız Ö; Pınarlı FA; Albayrak A; Uğurlu N; Tiryaki M; Delibaşi T
J Ocul Pharmacol Ther; 2014 May; 30(4):306-12. PubMed ID: 24494746
[TBL] [Abstract][Full Text] [Related]
22. Serine protease inhibitor A3K suppressed the formation of ocular surface squamous metaplasia in a mouse model of experimental dry eye.
Lin Z; Zhou Y; Wang Y; Zhou T; Li J; Luo P; He H; Wu H; Liu Z
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5813-20. PubMed ID: 25103264
[TBL] [Abstract][Full Text] [Related]
23. Role of CD4+ T Helper Cells in the Development of BAC-Induced Dry Eye Syndrome in Mice.
Ouyang W; Wu Y; Lin X; Wang S; Yang Y; Tang L; Liu Z; Wu J; Huang C; Zhou Y; Zhang X; Hu J; Liu Z
Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):25. PubMed ID: 33492357
[TBL] [Abstract][Full Text] [Related]
24. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
[TBL] [Abstract][Full Text] [Related]
25. Effects of Vitamin A on Expressions of Apoptosis Genes Bax and Bcl-2 in Epithelial Cells of Corneal Tissues Induced by Benzalkonium Chloride in Mice with Dry Eye.
Zhang W; Li W; Zhang C; Zhu C; Yi X; Zhou Y; Lv Y
Med Sci Monit; 2019 Jun; 25():4583-4589. PubMed ID: 31257361
[TBL] [Abstract][Full Text] [Related]
26. Protective Effect of Allyl Isothiocyanate in an Experimentally Induced Rat Model for Dry Eye Syndrome.
Muz OE; Orhan C; Tuzcu M; Er B; Morde AA; Padigaru M; Ozercan IH; Sahin K
Curr Eye Res; 2022 May; 47(5):704-714. PubMed ID: 35176939
[TBL] [Abstract][Full Text] [Related]
27. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
28. Influence of benzalkonium chloride on langerhans cells in corneal epithelium and development of dry eye in healthy volunteers.
Zhivov A; Kraak R; Bergter H; Kundt G; Beck R; Guthoff RF
Curr Eye Res; 2010 Aug; 35(8):762-9. PubMed ID: 20673054
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease.
Zhang R; Park M; Richardson A; Tedla N; Pandzic E; de Paiva CS; Watson S; Wakefield D; Di Girolamo N
Ocul Surf; 2020 Jan; 18(1):158-169. PubMed ID: 31740391
[TBL] [Abstract][Full Text] [Related]
30. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
[TBL] [Abstract][Full Text] [Related]
31. Astragalus Ⅳ ameliorates the dry eye injury in rabbit model via MUC1-ErbB1 pathway.
Chu L; Ma S; Chen Z; Cao W
Eur J Histochem; 2021 Apr; 65(2):. PubMed ID: 33792228
[TBL] [Abstract][Full Text] [Related]
32. Rodent models for dry eye syndrome: Standardization using benzalkonium chloride and scopolamine hydrobromide.
Chaudhari P; Satarker S; Thomas R; Theruveethi N; Ghate V; Nampoothiri M; Lewis SA
Life Sci; 2023 Mar; 317():121463. PubMed ID: 36731648
[TBL] [Abstract][Full Text] [Related]
33. Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye.
Chen X; Lee S; Zhang T; Duan T; Pasricha ND; Schallhorn JM; Levin MH; Koprivica V; Verkman AS
J Ocul Pharmacol Ther; 2020 Apr; 36(3):147-153. PubMed ID: 31934802
[No Abstract] [Full Text] [Related]
34. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Artificial Tears Based on an Extract of
Carpena-Torres C; Pintor J; Huete-Toral F; Martin-Gil A; Rodríguez-Pomar C; Martínez-Águila A; Carracedo G
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769429
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
Kim YH; Jung JC; Jung SY; Yu S; Lee KW; Park YJ
Cornea; 2016 Feb; 35(2):234-42. PubMed ID: 26619385
[TBL] [Abstract][Full Text] [Related]
37. A murine model of dry eye induced by topical administration of erlotinib eye drops.
Yang QC; Bao J; Li C; Tan G; Wu AH; Ye L; Ye LH; Zhou Q; Shao Y
Int J Mol Med; 2018 Mar; 41(3):1427-1436. PubMed ID: 29286080
[TBL] [Abstract][Full Text] [Related]
38. Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy.
Chintala SK; Pan J; Satapathy S; Condruti R; Hao Z; Liu PW; O'Conner CF; Barr JT; Wilson MR; Jeong S; Fini ME
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674497
[TBL] [Abstract][Full Text] [Related]
39. Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.
Vijmasi T; Chen FY; Balasubbu S; Gallup M; McKown RL; Laurie GW; McNamara NA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5401-9. PubMed ID: 25034600
[TBL] [Abstract][Full Text] [Related]
40. Neurosensory abnormalities and stability of a mouse model of dry eye disease.
Suanno G; Fonteyne P; Ferrari G
Exp Eye Res; 2023 Jul; 232():109516. PubMed ID: 37209768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
